ICON experts frequently author or contribute to industry trade press. The following are some recent articles.
The Significant Role of a Robust Regulatory Intelligence Process in Global Safety Submissions
A thought leadership article on pharmacovigilance, written by Arinder Sihota and Trupti Gurjar, which featured in the March 2020 edition of Pharma Focus.
The Power of Patients
Patient engagement is permeating all spheres of the healthcare ecosystem
The Promise of IoMT
A thought leadership article by David Novotny and Marie McCarthy, which focuses on the advances in connected devices such as wearable biosensors and mobile trackers.
How digital is reversing fortunes in R&D
A new report lays out the ways digital transformation could reverse the trend of declining ROI in pharma R&D.
Best Practices in Seasonal Vaccine Efficacy Studies: Tips for Successful Planning and Execution
A thought leadership piece by Cindy Dukes exploring the unique challenges in planning and executing a seasonal vaccine study.
Is Pharma Finally Heading for Launch Excellence?
The traditional approaches to launching a new medicine still tend to sit in the commercial function, but they need to better align with HEOR, medical affairs and clinical teams.Read more in the February issue of PME.
Cell Therapies: The Living End of Growth Opportunities
ICON's Martin Lachs comments on the exponential growth of the cell and gene therapy market driven by the increasing prevalence of chronic diseases, launch of new products, regulatory support, and improved manufacturing expertise.
Rethinking Patient and Site Engagement
A thought leadership article by Dr. Nuala Murphy exploring how protocol optimisation can be instrumental in improving patient and site engagement to mobilise increasingly complex clinical trials.
Decentralized and Hybrid Trials
An article by Gretchen Goller and Kristin Kinlaw which outlines patient feedback from a recent survey regarding the use of decentralized and hybrid trials in the pharmaceutical industry.
Keeping it Real: Challenges and Benefits of Integrating AI and Machine Learning into Pharma R&D
ICON's CIO Tom O'Leary provides expert commentary on integrating AI and machine learning into Pharma R&D in this January 2020 Bio IT World Article.